Cite

HARVARD Citation

    Tfelt-Hansen, P. et al. (2021). Critique of the analysis of the time course for the antimigraine effect of ubrogepant 50 mg. Clinical relevance versus statistical significance. Cephalalgia. pp. 1276-1278. [Online]. 
  
Back to record